4//SEC Filing
Ehrlich Christopher B 4
Accession 0001213900-24-026821
CIK 0001870404other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 9:27 PM ET
Size
5.6 KB
Accession
0001213900-24-026821
Insider Transaction Report
Form 4
Ehrlich Christopher B
DirectorChairman and CEO
Transactions
- Award
Stock Option (Right to Buy)
2024-03-25+572,182→ 572,182 totalExercise: $1.77Exp: 2034-03-24→ Common Stock (572,182 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in forty-eight (48) monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
CERO THERAPEUTICS HOLDINGS, INC.
CIK 0001870404
Entity typeother
Related Parties
1- filerCIK 0001293973
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 9:27 PM ET
- Size
- 5.6 KB